The Clinical Validity and Safety of IOP Injection MRI Contrast Agent in Hepatocellular Carcinoma
Status:
Completed
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
This study is an exploratory study aiming to collect data on sensitivity and positive
predictive value of IOP-enhanced (MPB-1523) MRI compared to dynamic multiphase MDCT for the
detection of HCC.